Showing results (261-270 of 294) with videos related to
Sort By:
Pageof 30
Clinical Trials (London, England)|December 2, 2005
Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis TrialLaura M Dember, James S Kaufman, Gerald J Beck, et al.Kidney International|March 11, 2011
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseTamara Isakova, Patricia Wahl, Gabriela S Vargas, et al.American Journal of Nephrology|February 28, 2022
A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and JapanNaohiko Fujii, Takayuki Hamano, Jesse Y Hsu, et al.Kidney Medicine|November 2, 2023
Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) StudyAlexander S Leidner, Xuan Cai, Leila R Zelnick, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 2019
Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) StudyTamara Isakova, Xuan Cai, Jungwha Lee, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 15, 2018
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC StudyRichard L Amdur, Harold I Feldman, Elizabeth A Dominic, et al.Journal of Hypertension|September 22, 2007
Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trialVibha Bhatnagar, Daniel T O'Connor, Nicholas J Schork, et al.Clinical Trials (London, England)|December 2, 2005
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis TrialBradley S Dixon, Gerald J Beck, Laura M Dember, et al.Hemodialysis International. International Symposium on Home Hemodialysis|November 14, 2015
Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trialPatrick H Pun, Safa Abdalla, Geoffrey A Block, et al.Journal of the American Society of Nephrology : JASN|February 11, 2022
Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC StudyJoshua D Bundy, Mahboob Rahman, Kunihiro Matsushita, et al.Pageof 30